Compounding pharmacy
Also called: 503A, 503B
Clinical reviewer: Jacob Moore, MD · Last checked September 16, 2026
What is a compounding pharmacy?
Compounding pharmacy is an umbrella term for a pharmacy or facility that combines, mixes, or alters ingredients into a drug tailored to a patient's needs. Rather than dispensing a mass-manufactured product, it operates under one of two federal pathways: a 503A pharmacy or a 503B outsourcing facility. Compounded drugs are not FDA-approved.
What does a compounding pharmacy do?
FDA describes compounding as a licensed pharmacist, licensed physician, or (at an outsourcing facility) someone under a pharmacist's supervision combining, mixing, or altering ingredients to create a medication tailored to one patient's needs [1]. Compounded drugs are not FDA-approved, meaning FDA does not review their safety, effectiveness, or quality before they reach a patient [1]. Compounded medications are not reviewed or approved by the FDA for safety or effectiveness.
What's the difference between a 503A pharmacy and a 503B facility?
A 503A compounding pharmacy is a state-licensed pharmacy that compounds a drug for a patient who has a prescription and is overseen mainly by the state board of pharmacy [2]. A 503B outsourcing facility registers with FDA, is inspected directly by FDA on a risk-based schedule, and, unlike a 503A pharmacy, must follow manufacturing-quality (CGMP) rules [2].
When are compounded drugs used?
FDA recommends compounded drugs be used only for patients whose needs an FDA-approved drug cannot meet, such as an allergy to an inactive ingredient or a need for a different dosage form [2]. Because compounded products skip FDA's premarket review, FDA also warns that poor compounding practices can cause contamination or incorrect ingredient amounts [2].
Related terms
Sources
This entry is for education and is not medical advice. Talk with a licensed clinician about your own situation before starting, stopping, or changing any treatment.
